{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:22:44Z","timestamp":1782976964339,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 HD012303"],"award-info":[{"award-number":["P50 HD012303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HD007203"],"award-info":[{"award-number":["T32 HD007203"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["fertstertscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&amp;S Science"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.xfss.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T04:59:25Z","timestamp":1625029165000},"page":"230-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ibuprofen inhibits key genes involved in androgen production in theca\u2013interstitial cells"],"prefix":"10.1016","volume":"2","author":[{"given":"Chelsea W.","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8200-3093","authenticated-orcid":false,"given":"V. Gabriel","family":"Garzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni J.","family":"Duleba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfss.2021.06.004_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0015-0282(03)00735-0","article-title":"Androgen excess is the key element in polycystic ovary syndrome","volume":"80","author":"Azziz","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2021.06.004_bib2","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2021.06.004_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.xfss.2021.06.004_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02371251","article-title":"Acute and chronic implantation of coiled wire intraneural electrodes during cyclical electrical stimulation","volume":"13","author":"Bowman","year":"1985","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.xfss.2021.06.004_bib5","first-page":"307","article-title":"Parakeratosis ostrcea-an unusual variant of rupoid psoriasis","volume":"54","author":"Handa","year":"1988","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.xfss.2021.06.004_bib6","first-page":"1318","article-title":"Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries","volume":"86","author":"Jakimiuk","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2021.06.004_bib7","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/en.2019-00588","article-title":"Inflammatory stimuli trigger increased androgen production and shifts in\u00a0gene expression in theca-interstitial cells","volume":"160","author":"Fox","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.xfss.2021.06.004_bib8","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2021.06.004_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/01443615.2011.553693","article-title":"Polycystic ovary syndrome and the peripheral blood white cell count","volume":"31","author":"Herlihy","year":"2011","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.xfss.2021.06.004_bib10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2265.2009.03523.x","article-title":"Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment","volume":"71","author":"Glintborg","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.xfss.2021.06.004_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.fertnstert.2008.10.070","article-title":"Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors","volume":"93","author":"Kaya","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2021.06.004_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2021.06.004_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2021.06.004_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","article-title":"Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome","volume":"48","author":"Gonzalez","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.xfss.2021.06.004_bib15","article-title":"Interleukin-6 levels in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xfss.2021.06.004_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","article-title":"Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial","volume":"92","author":"Banaszewska","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2021.06.004_bib17","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1210\/jc.2009-1674","article-title":"Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial","volume":"94","author":"Banaszewska","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2021.06.004_bib18","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1210\/jc.2011-0501","article-title":"Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment","volume":"96","author":"Banaszewska","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2021.06.004_bib19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.fertnstert.2005.09.030","article-title":"Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial","volume":"85","author":"Duleba","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2021.06.004_bib20","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1210\/jc.2016-1858","article-title":"Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial","volume":"101","author":"Banaszewska","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2021.06.004_bib21","doi-asserted-by":"crossref","first-page":"E715","DOI":"10.1073\/pnas.1715035115","article-title":"Ibuprofen alters human testicular physiology to produce a state of compensated hypogonadism","volume":"115","author":"Kristensen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xfss.2021.06.004_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1757-2215-7-21","article-title":"Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis","volume":"7","author":"Ortega","year":"2014","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.xfss.2021.06.004_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2018-00075","article-title":"Ovulation: parallels with inflammatory processes","volume":"40","author":"Duffy","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.xfss.2021.06.004_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/humupd\/dmv026","article-title":"Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway","volume":"21","author":"Duffy","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2021.06.004_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0015-0282(01)02829-1","article-title":"The effect of nonsteroidal anti-inflammatory drugs on ovulation: a prospective, randomized clinical trial","volume":"76","author":"Uhler","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2021.06.004_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.xfss.2021.06.004_bib27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41374-018-0160-2","article-title":"Lipopolysaccharide promotes lung fibroblast proliferation through autophagy inhibition via activation of the PI3K-Akt-mTOR pathway","volume":"99","author":"Xie","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.xfss.2021.06.004_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nri.2015.7","article-title":"Converging roles of caspases in inflammasome activation, cell death and innate immunity","volume":"16","author":"Man","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xfss.2021.06.004_bib29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic processing of interleukin-1 family cytokines: variations on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.xfss.2021.06.004_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.xfss.2021.06.004_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.xfss.2021.06.004_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xfss.2021.06.004_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/030006058501300110","article-title":"Ibuprofen: plasma concentrations in man","volume":"13","author":"Janssen","year":"1985","journal-title":"J Int Med Res"}],"container-title":["F&amp;S Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X21000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X21000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:06:46Z","timestamp":1762981606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666335X21000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2666335X21000501"],"URL":"https:\/\/doi.org\/10.1016\/j.xfss.2021.06.004","relation":{},"ISSN":["2666-335X"],"issn-type":[{"value":"2666-335X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibuprofen inhibits key genes involved in androgen production in theca\u2013interstitial cells","name":"articletitle","label":"Article Title"},{"value":"F&S Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfss.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}